|16th September 2015
We are pleased to announce that Blue Latitude have been reappointed to provide Janssen with strategic support and creative marketing services for their brand teams in the EMEA region. Following this renewed three year contract, we will continue our successful partnership with Janssen, offering our full breadth of services across a wide range of therapy areas. Talking about the partnership, leadership from both companies had the following to say;
The Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing and solving the most important unmet medical needs of our time, including oncology (e.g., multiple myeloma and prostate cancer), immunology (e.g., psoriasis), neuroscience (e.g., schizophrenia, dementia and pain), infectious disease (e.g., HIV/AIDS, hepatitis C and tuberculosis), and cardiovascular and metabolic diseases (e.g., diabetes). Driven by a commitment to patients, Janssen develops sustainable, integrated healthcare solutions by working side-by-side with healthcare stakeholders, based on partnerships of trust and transparency. For their latest news, follow Janssen on Twitter: @JanssenEMEA.
|13th December 2018
Blue Latitude Health is proud to announce that we have received a two-star accreditation from Best Companies after completing their accreditation survey.
|10th December 2018
Blue Latitude Health announces a new partnership with Fishawack Group of Companies, fuelling our global growth.
|30th November 2018
We spoke to each of BLH’s 2018 Mo’bros to find out why they chose to get involved with Movember this year and support men’s health.